These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11167858)

  • 1. A case of refractory idiopathic pure red cell aplasia responsive to fludarabine treatment.
    Ahn J; Lee K; Lee J; Lee J; Park C; Chi H; Kim W
    Br J Haematol; 2001 Feb; 112(2):527-9. PubMed ID: 11167858
    [No Abstract]   [Full Text] [Related]  

  • 2. Retreatment with fludarabine and cyclosporine for one case of refractory pure red cell aplasia.
    He GS; Zhang X; Wu DP; Sun AN; Miao M; Wang XL; Jin ZM
    Chin Med Sci J; 2008 Mar; 23(1):60-2. PubMed ID: 18437913
    [No Abstract]   [Full Text] [Related]  

  • 3. Refractory pure red-cell aplasia associated with B chronic lymphocytic leukemia successfully treated by fludarabine.
    Sandra S; Real E; Pastor E; Grau E
    Haematologica; 1999 Dec; 84(12):1154-5. PubMed ID: 10586218
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of red cell aplasia in CLL with fludarabine.
    Ribeiro I; Tsatalas C; Catovsky D
    Leukemia; 1999 Nov; 13(11):1897. PubMed ID: 10557069
    [No Abstract]   [Full Text] [Related]  

  • 5. Refractory pure red cell aplasia associated with B-CLL: successful treatment with a combination of fludarabine, cyclosporin A and erythropoietin.
    Shimoni A; Shvidel L; Klepfish A; Shtalrid M; Sigler E; Berrebi A
    Leukemia; 1999 Jan; 13(1):142-3. PubMed ID: 10049051
    [No Abstract]   [Full Text] [Related]  

  • 6. [Acquired pure red cell aplasia in a patient with B cell chronic lymphocytic leukemia after fludarabine therapy].
    Tsuji T; Hirano T; Yamasaki H; Tuda H
    Rinsho Ketsueki; 2015 Jun; 56(6):705-10. PubMed ID: 26256883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytopenia and fludarabine.
    Jaccard A; Oksenhendler E; Clauvel JP
    Lancet; 1993 Oct; 342(8878):1049-50. PubMed ID: 8105278
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of pure red cell aplasia that is resistant to conventional immunosuppressive therapy with intermittent administration of methotrexate.
    Sato N; Takatani O; Hosoi T; Shirafuji N; Urabe A; Takaku F
    Acta Haematol; 1989; 82(2):98-101. PubMed ID: 2508403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistant pure red cell aplasia after allogeneic bone marrow transplantation with major ABO mismatch treated by purified CD34+ cell infusion.
    Woo HY; Min CK; Lee SM; Cho HS; Kim SY; Lee S; Lee JW; Min WS; Kim CC; Kim Y
    Eur J Haematol; 2006 Feb; 76(2):160-3. PubMed ID: 16405438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine dependent pure red cell aplasia: a case presentation.
    Al-Issa K; Visconte V; Rogers HJ; Dembla V; Lichtin AE; Tiu RV
    Blood Cells Mol Dis; 2015 Mar; 54(3):281-3. PubMed ID: 25488615
    [No Abstract]   [Full Text] [Related]  

  • 11. Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia.
    Au WY; Lam CC; Chim CS; Pang AW; Kwong YL
    Leuk Res; 2005 Oct; 29(10):1213-5. PubMed ID: 16111536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful re-challenge with darbepoetin in a patient with rHu-EPO-induced pure red cell aplasia refractory to immunosuppressive drugs.
    Viron B; Dupuy CA; Kolta A; Casadevall N
    Nephrol Dial Transplant; 2008 Jul; 23(7):2416-8. PubMed ID: 18388118
    [No Abstract]   [Full Text] [Related]  

  • 13. Pure red-cell aplasia with fludarabine for chronic lymphocytic leukaemia.
    Leporrier M; Reman O; Troussard X
    Lancet; 1993 Aug; 342(8870):555. PubMed ID: 8102691
    [No Abstract]   [Full Text] [Related]  

  • 14. [Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia].
    Antich Rojas J; Balaguer H; Cladera A
    Sangre (Barc); 1997 Jun; 42(3):254-6. PubMed ID: 9381277
    [No Abstract]   [Full Text] [Related]  

  • 15. The pharmacokinetic analysis of cyclosporine is essential for the management of refractory pure red cell aplasia.
    Kato Y; Tajima K; Suzuki I; Kohno K; Hiroshima Y; Kato T
    Ann Hematol; 2012 Dec; 91(12):1991-2. PubMed ID: 22836945
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment of refractory pure red cell aplasia by buserelin acetate.
    Nara N; Tohda S
    Acta Haematol; 1994; 92(1):42-5. PubMed ID: 7985482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with cyclosporine A of pure red-cell aplasia occurring 11 years after thymectomy.
    Di Mario A; De Stefano V; Mele L; Musumeci V; Leone G
    Eur J Haematol; 1998 Sep; 61(3):221-2. PubMed ID: 9753422
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment of pure red cell aplasia secondary to chronic lymphocytic leukemia using cyclosporine A.
    Aviv A; Chubar E; Bennett M
    Isr Med Assoc J; 2014 Jan; 16(1):63-5. PubMed ID: 24575511
    [No Abstract]   [Full Text] [Related]  

  • 19. Acquired pure red cell aplasia in a child.
    Sharma RA; Hiwarkar P; Manglani MV; Muralidhar HP
    J Postgrad Med; 2002; 48(1):37-8. PubMed ID: 12082327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pure red cell aplasia in patients with chronic lymphocytic leukaemia treated with cladribine.
    Robak T; Kasznicki M; Bloński JZ; Dmoszyńska A; Skotnicki AB
    Br J Haematol; 2001 Mar; 112(4):1083-5. PubMed ID: 11324637
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.